RISK OF MULTIPLE DRUG INTERACTIONS POTENTIALLY LINKED TO SAFETY IN PATIENTS RECEIVING PANGENOTYPIC DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C

被引：0
|
作者：
Turnes, Juan [1 ]
Garcia-Herola, Antonio [2 ]
Morillo, Ramon [3 ]
Mendez, Marinela [4 ]
Rueda, Magdalena [4 ]
Hernandez, Candido [5 ]
Sicras-Mainar, Antoni [6 ]
机构：
[1] CHU, Gastroenterol & Hepatol Dept, Pontevedra, Spain
[2] Hosp Marina Baixa de Villajoyosa, Digest Med Dept, Alicante, Spain
[3] AGS Sur Sevilla, Hosp Valme, Hosp Pharm, Seville, Spain
[4] Gilead Sci SL, Med Affairs, Madrid, Spain
[5] Gilead Sci Europe Ltd, Global Med Affairs, London, England
[6] Atrys Hlth, Hlth Econ & Outcomes Res, Barcelona, Spain
来源：
GUT | 2022年 / 71卷
关键词：
D O I：
10.1136/gutjnl-2022-IDDF.125
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
IDDF2022-A
引用
收藏
页码：A97 / A98
页数：2
相关论文
共 50 条
  • [1] Risk of multiple drug interactions potentially linked to safety in patients receiving pangenotypic direct-acting antivirals for the treatment of hepatitis C
    Turnes, J.
    Garcia-Herola, A.
    Morillo, R.
    Mendez, M.
    Rueda, M.
    Hernandez, C.
    Sicras-Mainar, A.
    Freismuth, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 42 - 42
  • [2] RISK OF MULTIPLE DRUG INTERACTIONS POTENTIALLY LINKED TO SAFETY IN PATIENTS RECEIVING PANGENOTYPIC DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C
    Turnes, Juan
    Garcia, Antonio
    Morillo-Verdugo, Ramon
    Mendez, Marinela
    Rueda, Magdalena
    Hernandez, Candido
    Sicras-Mainar, Antoni
    HEPATOLOGY, 2021, 74 : 574A - 575A
  • [3] Treatment of hepatitis C: the use of the new pangenotypic direct-acting antivirals in "special populations"
    Pol, Stanislas
    Parlati, Lucia
    LIVER INTERNATIONAL, 2018, 38 : 28 - 33
  • [4] Safety of direct-acting antivirals in the treatment of chronic hepatitis C
    Ridruejo, Ezequiel
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (03) : 307 - 319
  • [5] Frequency and impact of potential multiple drug-drug interactions (DDIs) associated with pangenotypic direct-acting antivirals in patients receiving opioid substitution therapy
    Umland, Tim
    Hintz, Andreas
    Niess, Gero
    Guendogdu, Mehtap
    Tacke, Frank
    JOURNAL OF HEPATOLOGY, 2021, 75 : S794 - S794
  • [6] IMPACT OF POLYPHARMACY AND AGING ON THE RISK OF MULTIPLE DRUG-DRUG INTERACTIONS (DDIS) IN HCV PATIENTS TREATED WITH PANGENOTYPIC DIRECT-ACTING ANTIVIRALS (PDAA)
    Mangia, Alessandra
    Toniutto, Pierluigi
    Coppola, Nicola
    Ancona, Domenica Daniela
    Andretta, Margherita
    Bartolini, Fausto
    Ferrante, Fulvio
    Lupi, Alessandro
    Palcic, Stefano
    Rizzi, Francesca Vittoria
    Re, Davide
    Nieto, Gema Alvarez
    Hernandez, Candido
    Perrone, Valentina
    Degli Esposti, Luca
    Fagiuoli, Stefano
    HEPATOLOGY, 2021, 74 : 566A - 567A
  • [7] DRUG-DRUG INTERACTIONS (DDIS) WITH PANGENOTYPIC DIRECT-ACTING ANTIVIRALS (DAAS) IN PATIENTS WITH HEPATITIS C; UNDERSTANDING THE POPULATIONS AT RISK AND REAL-WORLD CARE MANAGEMENT
    Curry, Michael P.
    Tsai, Naoky C. S.
    Bacon, Bruce R.
    Flamm, Steven L.
    Younossi, Zobair M.
    Milligan, Scott
    Wick, Nicole
    Afdhal, Nezam H.
    HEPATOLOGY, 2019, 70 : 903A - 904A
  • [8] Drug Interactions With Direct-Acting Antivirals for Hepatitis C: Implications for HIV and Transplant Patients
    Burgess, Sarah
    Partovi, Nilufar
    Yoshida, Eric M.
    Erb, Siegfried R.
    Azalgara, Vladimir Marquez
    Hussaini, Trana
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (06) : 674 - 687
  • [9] Drug-drug interactions (DDIs) with pangenotypic direct-acting antivirals (DAAs) in patients with hepatitis C; understanding the populations at risk and real-world care management
    Curry, Michael
    Tsai, Naoky
    Bacon, Bruce
    Flamm, Steven
    Younossi, Zobair
    Milligan, Scott
    Wick, Nicole
    Afdhal, Nezam
    JOURNAL OF HEPATOLOGY, 2020, 73 : S355 - S356
  • [10] Use of psychiatric medication and drug interactions in patients with hcv infection treated with pangenotypic direct-acting antivirals
    Turnes, J.
    Garcia-Herola, A.
    Verdugo, R. M.
    Mendez, M.
    De Alvaro, C.
    Hernandez, C.
    Sicras-Mainar, A.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S71 - S71
12345